Biochemistry, Genetics and Molecular Biology
ABCA1
50%
Alanine Transaminase
10%
Allele
25%
Aspartate Transaminase
10%
Autosomal Dominant Inheritance
10%
Autosomal Dominant Polycystic Kidney
50%
Cell Cycle Regulation
10%
Clopidogrel
33%
Codon
50%
Cyclic Adenosine Monophosphate
10%
Cyclic Guanosine Monophosphate
10%
CYP2C19
50%
Embryonic Hemoglobin
100%
Exome Sequencing
35%
Fetal Hemoglobin
70%
GATA6
10%
Gene Deletion
50%
Gene Polymorphism
25%
Genetic Risk
20%
Genetic Susceptibility
16%
Genetics
31%
Genome-Wide Association Study
10%
Genotyping
50%
Globin
74%
Globin Gene
100%
Glycosphingolipid
10%
Hemoglobin A2
100%
Human Genome
10%
Mammalian Target of Rapamycin
10%
Methylglyoxal
25%
Mir-184
10%
Next Generation Sequencing
10%
NOD2
50%
Normal Human
17%
Offspring
10%
Phosphatidylinositol-4,5-bisphosphate 3-Kinase
12%
PKD1
38%
Point Mutation
10%
Polygenic Score
50%
Polymerase Chain Reaction
15%
Prevalence
42%
Progesterone Receptor
12%
Promoter Region
8%
Rare Variant
30%
Reticulocyte
10%
Single-Nucleotide Polymorphism
10%
Solute Carrier Family
10%
TLR4
50%
TSC2
11%
Tuberous Sclerosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Base
10%
Clopidogrel
33%
CYP2C19
50%
Globin
50%
Hemoglobin A2
50%
Hemoglobin F
50%
Hemoglobinopathy
10%
Hormone Receptor
50%
Normal Human
10%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
10%
Prevalence
10%
Progesterone Receptor
10%
Sickle Cell Anemia
10%
Thalassemia
50%
Medicine and Dentistry
Breast Cancer Classification
12%
Cell Cycle Regulation
6%
Cyclic GMP
6%
Exome Sequencing
50%
Genome Wide Association Study
7%
Globin
6%
Globin Gene
18%
Glycosphingolipid
6%
Human Genome
7%
Mammalian Target of Rapamycin
6%
Next Generation Sequencing
6%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
12%
PKD1
29%
Polycystic Kidney Disease
50%
Polygenic Risk Score
50%
Progesterone Receptor
6%
Progesterone Receptor
6%
Reticulocyte
6%
Sanger Sequencing
14%
